<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hoyle, Brian</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Wysham, Carol H.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Greater HbA1c Reduction in Uncontrolled Type 2 Diabetes with Once-Weekly Exenatide Autoinjection</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">12-14</style></pages><abstract><style  face="normal" font="default" size="100%">Patients with uncontrolled type 2 diabetes display greater reductions in HbA1c using a regimen of a once-weekly autoinjection of exenatide as compared with twice-daily injections of exenatide. The results of the randomized, double-blind Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes study [DURATION-NEO-1; NCT01652716] are presented in this article.</style></abstract><number><style face="normal" font="default" size="100%">20</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>